论文信息 - Outcome of patients with chronic myeloid leukemia with multiple ABL1 kinase domain mutations receiving tyrosine kinase inhibitor therapy - 字舞流文

Outcome of patients with chronic myeloid leukemia with multiple ABL1 kinase domain mutations receiving tyrosine kinase inhibitor therapy

H. Kantarjian | J. Cortes | A. Quintás-Cardama | S. Verstovsek | F. Ravandi | G. Borthakur | E. Jabbour | S. O'brien | J. Shan | A. Quintás-Cardama